Patient characteristics of the CLL1 study cohort.
收藏数据链接：
官方服务：
资源简介：
*high risk, as defined by the following: serum thymidine kinase level>7.0 U/L, β2-microglobulin>3.5 mg/l level, presence of non-nodular bone marrow infiltration, LDT**For definition of cytogenetic risk see legend to Table 1. All risk parameters except LDT were determined at the time of study entry.
创建时间：
2015-12-02
